Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Foghorn Therapeutics Inc. (FHTX) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$5.95M |
|
$-18.83M |
|
-- |
|
$5.95M |
|
$28.86M |
|
$-22.91M |
|
$4.08M |
|
$-18.83M |
|
$-18.83M |
|
$-18.83M |
|
$-18.83M |
|
$-18.83M |
|
$-18.83M |
|
$-22.91M |
|
$-22.90M |
|
62.85M |
|
62.85M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$225.42M |
|
$10.35M |
|
$33.27M |
|
$258.69M |
|
$71.31M |
|
-- |
|
$249.03M |
|
$320.34M |
|
$-61.65M |
|
$-61.65M |
|
$-61.65M |
|
55.72M |
|
| Cash Flow Statement Financials | |
$-23.97M |
|
$29.40M |
|
$0.14M |
|
$57.16M |
|
$62.73M |
|
$5.57M |
|
$2.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.16 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-384.96% |
|
-384.96% |
|
-- |
|
-316.43% |
|
-316.43% |
|
$-24.00M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
30.55% |
|
30.55% |
|
-7.28% |
|
30.55% |
|
$-1.11 |
|
$-0.38 |
|
$-0.38 |
|